TG Therapeutics

is a biopharmaceutical company focused on the development of
novel treatments for B-cell malignancies and autoimmune diseases.

 

Click for full image >>

For Investors

NASDAQ: TGTX
Stock Quote at: Jan 18, 4:00PM EST

Last: $4.55

Change: ($0.05) (1.09%)

Quotes provided by Google - Min 15 minute delay